Navigation Links
Anthrax vaccine produced

Indian scientists have produced a more effective vaccine for anthrax and they claim that it could be less mephitic and longer lasting than that which is presently available.It has been developed by a team, from the Centre for Biotechnology// at Jawaharlal Nehru University, led by Dr Rakesh Bhatnagar.

It is made up of harmless mutant forms of three key proteins that together make the toxin that does the damage to humans infected with anthrax. The protective antigen, lethal factor and edema factor. Individually, the proteins are non-toxic, but in combination they can be deadly. The vital protein is protective antigen, which binds to host cells and enables the other two proteins to enter.

A harmless form of protective antigen is the main ingredient of the new vaccine. However, it also includes trace amounts of the harmless forms of lethal factor and edema factor, which boost the vaccine's effectiveness.

Dr Bhatnagar said that if further tests proved successful, the new vaccine could replace the form presently used, which although effective has many side effects. Dr Bhatnagar was motivated to find a vaccine for anthrax following a major epidemic among animals in West Bengal seven years ago.


'"/>




Page: 1

Related medicine news :

1. Anthrax drug doxycycline could stunt fetal growth
2. Drugs For Anthrax May Interfere With Oral Contraceptives
3. Cipro Has Cheaper Cousins to Treat Anthrax
4. Panacea Biotech To Market Anthrax Vaccine
5. Prototype Detector detects Anthrax Quickly
6. Effective And Economical Agent For Anthrax
7. Anthrax hammers immune system
8. Identifying Predictors Of Anthrax
9. New Inhalation Anthrax Vaccine
10. Anthrax Scare In Tamil Nadu State of India
11. Anthrax Scare In Tamil Nadu State of India
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anthrax vaccine produced

(Date:1/7/2009)....J., Jan. 7 Seabrook House, an internationally re... announce its plans for expanding their patient ca... of the ways Seabrook House is promoting the messa...at treatment works. Seabrook House,s vision is to ...it and to educate the public at large in an effort...
(Date:1/7/2009)...Jan. 7 Synthetech, Inc.,(OTC Bulletin Board: NZYM...nt,Awards for their outstanding accomplishments in...Security (EHS&S) Planning and Operations, and ... presented by the Synthetic Organic,Chemical Manuf...Stewards,SOCMA,s EHS&S improvement initiative....
(Date:1/7/2009)...Jan. 7 Eli Lilly and Company,(NYSE: LLY ) will ...ter and,full year of 2008 on Thursday, January 29,...on that day with the investment community and medi...mance. , The conference call will be held from... the general public can access a live webcast of t...
(Date:1/7/2009)...s Seek Quality Online Tools , To Manage Family,s ...l Dentistry Creates Comprehensive Web Portal , ,...he ones who make most decisions in American househ... to a family,s overall dental and oral health care...ere not sure where to turn for help in finding suc...
Breaking Medicine News(10 mins):Health News:Seabrook House Embraces the New Year with New Programs 2Health News:Seabrook House Embraces the New Year with New Programs 3Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 2Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 4Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 5
...vealed that middle-aged to older U.S. residents ap...an their English counterparts. // The results of t... JAMA. The United States spends considerably mor...74) than the United Kingdom ($2,164). However, whe...
... Center has compelled nurses who did not get their...Nurses Association union has filed a complaint wit...lations Board (NLRB). This complaint has been the...n the hospital, its nurses and the union. The NLRB...
...t lack of insurance means worse care when it comes...er diseases early, even for the relatively well of... a primary care internist in the Robert Wood Johns...niversity, explained that lacking in health insura...
...ormer commissioner of the Food and Drug Administra... following accusations of financial improprieties....t a grand jury had begun a criminal investigation ... have told a federal magistrate, in a telephone he...
Other Medicine News:Health News:Americans-Not So Healthy After All 2Health News:Lack Of Insurance Means Worse Care For Uninsured 2Health News:Lack Of Insurance Means Worse Care For Uninsured 3
(Date:1/5/2009)... BETHESDA, Md., Jan. 5 /PRNewswire-FirstCall/ -...utical company developing novel, proprietary,anti...nd autoimmune diseases,provides an outlook on ke... Micromet intends to provide an update on its rese...ents: , -- April 12 to 16, 2009: Update on ...
(Date:12/29/2008)...BETHESDA, Md., Dec. 29 ...an Research Protection was announced today by Dr. ... Health Improvement Institute. , , The winner ... M.D. Anderson Cancer Center -- for its best pr...This program provides for 1) enhanced human subjec...
(Date:12/17/2008)...ificant milestone met in development and validatio... ASHLAND, Mass., Dec. 17 MatTek C...ic Advisory Committee (ESAC) endorsed the scientif...n Test (SIT) at its November meeting. ESAC conclu...ccuracy and reliability for the prediction of skin...
(Date:12/17/2008)...FRANCISCO, Dec. 17 Mediv...t it has completed patient enrollment in a,Phase ... novel androgen,receptor antagonist, in castratio... will seek approval from the U.S. Food and Drug Ad... trials next year. , The open-label, U.S. P...
Breaking Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 1At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 2At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 3Air Quality Action Day Forecast Thursday in All Regions 26056 1Air Quality Action Day Forecast Thursday in All Regions 26056 2New nano device detects immune system cell signaling 26053 1New nano device detects immune system cell signaling 26053 2New nano device detects immune system cell signaling 26053 3New nano device detects immune system cell signaling 26053 4New nano device detects immune system cell signaling 26053 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 1Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 2Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 3Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 4Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 6
...lished today in the Journal of the National Cancer...d, 2 May 2007 - In a study published today in,the ...vative cancer,drug MabThera was shown to improve o...ss of the chemotherapy regimen used.1 The,review f... seen for,the first time in patients with mantle c...
... May 1, 2007—The drug levosimendan did not i...art failure when,compared with a more widely-used ...g to a study in the May 2 issue of, JAMA . , Acute...ailure,characterized by inability of the heart to ...mon cause of hospitalization worldwide,but approp...
Other Medicine Technology:MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: